EI
IMMU

EAM Investors’s Immunomedics Inc IMMU Stock Holding History

EAM Investors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-53,540
Closed -$1.9M – 391
2020
Q2 		$1.9M Buy
+53,540
New +$1.57M 0.42% 92
2018
Q4 		– Sell
-98,026
Closed -$2.04M – 354
2018
Q3 		$2.04M Sell
98,026
-49,374
-33% -$1.17M 0.3% 149
2018
Q2 		$3.49M Buy
147,400
+97,120
+193% +$1.95M 0.55% 48
2018
Q1 		$735K Sell
50,280
-11,132
-18% -$182K 0.12% 229
2017
Q4 		$992K Sell
61,412
-326,204
-84% -$3.85M 0.18% 202
2017
Q3 		$5.42M Sell
387,616
-119,498
-24% -$1.19M 0.72% 16
2017
Q2 		$4.48M Buy
507,114
+370,086
+270% +$2.6M 0.74% 14
2017
Q1 		$887K Buy
+137,028
New +$694K 0.14% 206
2013
Q4 		– Sell
-188,594
Closed -$1.17M – 374
2013
Q3 		$1.17M Sell
188,594
-325
-0.2% -$1.87K 0.23% 189
2013
Q2 		$1.03M Buy
+188,919
New +$621K 0.22% 218

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

EAM Investors's IMMU Position: Q3 2020 in Review

EAM Investors sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 53,540 shares — an estimated $1.9M sold.

EAM Investors first reported a position in IMMU in Q2 2013 and held it in 10 quarters. The position peaked at $5.42M in Q3 2017. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • EAM Investors reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • EAM Investors sold 53,540 Immunomedics Inc shares in Q3 2020, an estimated $1.9M.
  • EAM Investors first reported a position in Immunomedics Inc in Q2 2013 and held it in 10 quarters.
  • EAM Investors's Immunomedics Inc position peaked at $5.42M in Q3 2017.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on EAM Investors's 13F filing for Q3 2020, filed 13 Nov 2020.